Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034913.xml
Download PDF
Phlebologie 2001; 30(06): 154-158
DOI: 10.1055/s-0037-1617309
DOI: 10.1055/s-0037-1617309
Leitlinien der DGP
Leitlinien zur Verödungsbehandlung der Varikose (ICD 10: I83.0, I83.1, I83.2, I83.9) Entwicklungsstufe: 1
Further Information
Publication History
Eingegangen:
25 September 2001
Publication Date:
14 March 2018 (online)
-
Literatur
- 1 Baccaglini U, Spreafico G, Castoro C, Sorrentino P. Consensus conference on sclerotherapy or varicose veins of the lower limbs. Phlebology 1997; 12: 2-16.
- 2 Baccaglini U, Stemmer R, Partsch H. Internationale Fragebogenaktion zur Praxis der Verödungsbehandlung. Phlebologie 1997; 26: 129-42.
- 3 Bergan JJ, Weiss RA, Goldman MP. Extensive tissue necrosis following high concentration sclerotherapy for varicose veins. Derm Surg 2000; 26: 535-42.
- 4 Cavezzi A, Frullini A. Echosclerotherapy in the short saphenous vein insufficiency: personal experience. Abstract UIP. Sydney 1998.
- 5 Conrad P, Malouf GM, Stacey MC. The australian polidocanol (aethoxysklerol) study. Results at 1 year. Phlebology 1994; 9: 17-20.
- 6 Conrad P, Malouf GM, Stacey MC. The australian polidocanol (aethoxysklerol) study. Results at 2 years. Derm Surg 1995; 21: 334-6.
- 7 Drake LA, Dinehart SM, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ. Guidelines of care for sclerotherapy treatment of varicose and teleangiectatic leg veins. J Am Acad Dermatol 1996; 34: 523-8.
- 8 Dover J, Sadick N, Goldman MP. The role of lasers and light sources in the treatment of leg veins. Derm Surg 1999; 25: 328-36.
- 9 Fegan WG. Continous compression technique of infecting varicose veins. Lancet 1963; 109-12.
- 10 Einarsson E, Eklöf B, Neglén P. Sclerotherapy or surgery as treatment for varicose veins: A prospective randomized study. Phlebology 1993; 8: 22-6.
- 11 Feied CF. Deep vein thrombosis: the risks of sclerotherapy in hypercoagulable states. Seminars in Dermatology 1993; 12 (Suppl. 02) 135-49.
- 12 Feied CF, Jackson JJ, Bren TS, Bond OB, Fernando CE, Young VC, Hashemiyoon RB. Allergic reactions to polidocanol for vein sclerosis. J Dermatol Surg Oncol 1994; 20: 466-8.
- 13 Feuerstein W. Schwere anaphylaktische Reaktion auf Hydroxypolyaethoxydodecan. VASA 1973; 3 (Suppl. 02) 292-4.
- 14 Fisher DA. Regarding extensive tissue necrosis following high concentration sclerotherapy for varicose veins. Dermatol surg 2000; 26 (11): 1081.
- 15 Flückiger P. Nicht-operative retrograde Varizenverödung mit Varisylschaum. Schweiz Med Wochenschr 1956; 48: 1368-70.
- 16 Frullini A, Cavezzi A. Ultrasound guided sclerotherapy in the treatment of long saphenaous vein insufficiency. Vasomed 1999; 11, Suppl. 1: 8.
- 17 Georgiev M. Postsclerotherapy hyperpigmentations. J Dermatol Surg Oncol 1993; 19: 649-52.
- 18 Geukens J, Rabe E, Bieber T. Embolia cutis medicamentosa of the foot after sclerotherapy. Eur J Dermatol 1999; 9: 132-3.
- 19 Goldman PM. Polidocanol (aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias. J Dermatol Surg Oncol 1989; 15: 204-9.
- 20 Goldman PM, Beaudoing D, Marley W, Lopez L, Butie A. Compression in the treatment of leg teleangiectasia: A preliminary report. J Dermatol Surg Oncol 1990; 16: 322-5.
- 21 Goldman MP, Sadick NS, Weiss RA. Cutaneous necrosis, telangiectatic matting and hyperpigmentation following sclerotherapy. Dermatol Surg 1995; 21: 19-29.
- 22 Goldmann PM. Complications of sclerotherapy. In: Gloviczki P, Yao J. (eds.) Handbook of venous disorders. Chapmann & Hall Medical; London: 1996: 374-93.
- 23 Grondin L, Young R, Wouters L. Sclérothérapie ècho-guidée et sécurité: Comparison des techniques. Phlebologie 1997; 50, 2: 241-45.
- 24 Guex JJ. Ultrasound guided sclerotherapy (USGS) for perforating veins. Hawaii Medical Journal 2000; 59 (Suppl. 06) 261-2.
- 25 Härtel SL. Fünf-Jahres-Nachuntersuchungsergebnisse der Sklerosierungstherapie nach Stemmer bei 118 Patienten mit primärer Varikosis. Vasomed 1998; 4: 272-3.
- 26 Henriet JP. One year experience with sclerotherapy of reticular veins and telangiectases using polidocanol foam in daily routine: feasibility, results, complications. Phlébologie 1997; 50 (Suppl. 03) 355-60.
- 27 Hohlbaum G. Über iatrogene Schäden bei der Varizensklerosierung. In: Staubesand J, Schöpf E. (Hrsg.) Neuere Aspekte der Sklerosierungstherapie. Springer Verlag, Berlin, Heidelberg, New York: 1990: 70-81.
- 28 Hübner K. Ambulante Therapie der Stammvarikose mittels Krossektomie und Sklerotherapie – ein Beitrag aus der Praxis des niedergelassenen Phlebologen. Phlebol 1991; 20: 104-8.
- 29 Kersting E, Hornschuh B, Bröcker E-B. Embolia cutis medicamentosa nach Varizensklerosierung mit Polidocanol. Phlebologie 1998; 27: 55-7.
- 30 Kreussler.. Aethoxysklerol-Fachinformation der Herstellerfirma, Chemische Fabrik Kreussler & Co GmbH, Stand 2/1996.
- 31 Malouf GM. Ambulatory venous surgery versus sclerotherapy. Hawaii Medical Journal 2000; 59: 248-9.
- 32 Massay RA. Regarding the use of compression stockings after sclerotherapy. Derm Surg 1999; 25: 517.
- 33 Mayer H, Brücke H. Zur Ätiologie und Behandlung der Varizen der unteren Extremität. Chir Praxis 1957; 4: 521-8.
- 34 McCoy S, Evans A, Spurrier N. Sclerotherapy for leg telangiectasia – a blinded comparative trial of polidocanol and hypertonic saline. Dermatol Surg 1999; 25: 381-6.
- 35 Mc Donagh B. Comments on the use of postsclerotherapy compression. Dermatol Surg 1999; 25 (Suppl. 06) 519-21.
- 36 Monfreux A. Traitement sclerosant des troncs sapheniens et leurs collaterales de gros calibre par la methode mus. Phlebologie 1997; 50: 351-3.
- 37 Norris MJ, Carlin MC, Ratz JL. Treatment of essential telangiectasia: effects of increasing concentrations of polidocanol. Journal of the American Academy of Dermatology 1989; 20 (Suppl. 04) 643-9.
- 38 Oesch A, Stirnemann P, Mahler F. The acute ischemic syndrome of the foot after sclerotherapy of varicose veins. Schweiz. Med. Wschr 1984; 114: 1155-8.
- 39 Reddy P, Wickers J, Terry T, Lamont P, Moller J, Dormandy JA. What is the correct period of bandaging following sclerotherapy?. Phlebology 1986; 217-20.
- 40 Pradalier A, Vincent D, Hentschel V, Cohen-Jonathan AM, Daniel E. Allergie aux sclérosants des varices. Rev. Fr. Allergol. 1995; 35 (Suppl. 05) 440-3.
- 41 Remy W, Vogt H-J, Borelli S. Embolia cutis medicamentosa – artige Hautnekrosen nach Sklerosierungsbehandlung. Phlebol Proktol 1978; 7: 67-72.
- 42 Rabe E. (Hrsg.). Grundlagen der Phlebologie. 2. Auflage, Viavital, Köln: 2000
- 43 Sadoun S, Benigni JP. La mousse de sclérosant: état de l´art. In: Rabe E. et al. (Hrsg.): Phlebology ´99,. Viavital, Köln: 1999: 146.
- 44 Schadeck M. Duplex-kontrollierte Sklerosierungsbehandlung der Vena saphena magna. Phlebol 1996; 25: 78-82.
- 45 Schadeck M, Allaert FA. Résultats à long terme de la Sclérothérapie des Saphènes internes. Phlebologie 1997; 50, 2: 257-62.
- 46 Schadeck M. Echo-Sclerotherapy. Phlébologie 1999; 52 Special Issue 10 103-6.
- 47 Schultz-Ehrenburg U, Tourbier H. Dopplerkontrollierte Verödungsbehandlung der Vena saphena magna. Phlebol Proktol 1984; 13: 117-22.
- 48 Seydewitz V, Staubesand J. Das ultrastrukturelle Substrat der Wirkung paravasal und intraarteriell applizierter Sklerosierungsmittel: Ein experimenteller Beitrag zum Problem iatrogener Schäden nach Sklerotherapie. In: Staubesand J, Schöpf E. (Hrsg.) Neuere Aspekte der Sklerosierungstherapie. Springer; Heidelberg: 1990: 40-65.
- 49 Sigg K. Neuere Gesichtspunkte zur Technik der Varizenbehandlung. Therap Umschau 1949; 6: 127-34.
- 50 Stanley PRW, Bickerton DR, Campbell WB. Injection sclerotherapy for varicose veins – a comparison of materials for applying local compression. Phlebology 1991; 37-9.
- 51 Tazelaar DJ, Neumann HAM, de Roos KP. Long cotton wool rolls as compression enhancers in macrosclerotherapy for varicose veins. Dermatol Surg 1999; 25 (Suppl. 01) 38-40.
- 52 Van der Plas JPL, Lambers JC, van Wersch JW, Koehler PJ. Reversible ischaemic neurological deficit after sclerotherapy of varicose veins. Lancet 1994; 343: 428.
- 53 Villavicencio J, Pfeifer J, Lohr J, Goldman M, Cranley R, Spence R. Sclerotherapy for varicose veins: Practice guidelines and sclerotherapy procedures. In: Glovicki P, Yao J. (eds) Handbook of venous disorders. Chapmann & Hall Medical; London: 1996: 337-54.
- 54 Vin F. Principes de la Sclérothérapie des Troncs Saphènes Internes. Phlebologie 1997; 50, 2: 229-34.
- 55 Weiss RA, Weiss MA. Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: hypertonics saline vs. polidocanol. J Dermatol Surg Oncol 1990; 16: 800-4.
- 56 Weiss RA, Sadick NS, Goldman MP, Weiss MA. Post-sclerotherapy compression: controlled comparative study of duration of compression and ist effects on clinical outcome. Derm Surg 1999; 25: 105-8.
- 57 Wenner L. Improvement of immediate and long-term results in sclerotherapy. Vasa 1986; 15 (Suppl. 02) 180-3.